MOP receptor | Search

Trials

24 participants · First posted Jul 15, 2024

Active, not recruiting

NCT01307384

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

165 participants · First posted Mar 2, 2011

Completed

NCT03924726

Osseous Evidence Behind Micro-osteoperforation in Accelerating Tooth Movement.

24 participants · First posted Apr 23, 2019

Drugs

View all 1695 →

Small Molecule

Investigational

Bergapten

C₁₂H₈O₄

docitaxel (Receptor)

TrkB receptor-agonizing mAbs (Wyeth)

Organizations

View all 54 →

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

News

View all 5102 →

2 years ago

Cebranopadol Shows Promise in Phase 3 Trial for Acute Pain Management

last year

Pipeline for Chronic Pain Treatment Expands with 25+ Drug Candidates Under Development

8 months ago

Trials

MARPE Effect With/Without MOP in Non-growing Patients

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

Osseous Evidence Behind Micro-osteoperforation in Accelerating Tooth Movement.

Drugs

Bergapten

docitaxel (Receptor)

TrkB receptor-agonizing mAbs (Wyeth)

Organizations

Arvinas Estrogen Receptor, Inc.

Arvinas Androgen Receptor, Inc.

Veru Inc

News

Cebranopadol Shows Promise in Phase 3 Trial for Acute Pain Management

Pipeline for Chronic Pain Treatment Expands with 25+ Drug Candidates Under Development

FDA Approves First-in-Class Non-Opioid Journavx for Acute Pain, Marking 20-Year Breakthrough